Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Archaeal keystone species in host microbiomes: Understanding and controlling Methanobrevibacter for Environmental and Health Benefits

Project description

Understanding the interaction of archaeal species in human gut microbiome function

Next to bacteria and eukaryotes, archaea represent the third domain of life on Earth. Archaea are an ancient group of single-celled microorganisms with unique characteristics and their representatives thrive in numerous habitats, including the mammalian gut. There, Methanobrevibacter species are particularly important, as they are involved in methane production in ruminants. These microorganisms modulate the microbiome by influencing the availability of essential vitamins and metabolites, but the exact mechanisms of archaea-bacteria-host interactions are unknown. The ERC-funded ARCH-METH project aims to study Methanobrevibacter’s interactions with bacteria in the human gut microbiome, where it acts as a dynamic orchestrator. A detailed understanding could enable the therapeutic modulation of microbiomes in humans, other animals and plants, as well as the modulation of methane production.

Objective

Archaea, the most ancient domain of life, play a crucial yet largely underappreciated role in human microbiomes and Earth's nutrient cycles. Among them, Methanobrevibacter species are particularly important for methane production in ruminants, accounting for up to 6% of anthropogenic greenhouse gas emissions and are prevalent in animal and plant microbiomes. In recent years, I have become intrigued by the impact of Methanobrevibacter on human physiology. Our research has shown that two distinct Methanobrevibacter species influence the availability of essential vitamins and metabolites by shaping the entire gut microbiome. Despite their recognized importance for health, our mechanistic understanding of archaeal dynamics and communication within the human microbial ecosystem remains limited due to technical challenges and a historical research bias. Methanobrevibacter never acts alone but relies on complex syntrophic, mutual interactions with bacteria. In these inter-domain networks, Methanobrevibacter functions as central hub. This creates an exciting possibility to strategically manipulate human microbiomes through a unique focus on the archaeal component. Given their distinct biological features, a major challenge is developing a robust methodological toolkit and engineering synthetic archaeal-bacterial consortia with therapeutic potentials. Through an integrative approach combining computational, experimental, and in vivo studies, I aim to elucidate the underlying mechanisms governing Methanobrevibacter networks, with the overall goal of elevating Methanobrevibacter to a central position in microbiome research. The gained knowledge will deepen scientific understanding of archaea and yield valuable applications in host-associated microbiomes. With extensive, globally unique expertise, a robust scientific network, and a validated methodological basis, I am poised to lead pioneering archaeome research with global implications for both environmental and human health.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-ADG

See all projects funded under this call

Host institution

MEDIZINISCHE UNIVERSITAT GRAZ
Net EU contribution
€ 2 500 000,00
Address
NEUE STIFTINGTALSTRASSE 6
8010 Graz
Austria
Region
Südösterreich Steiermark Graz
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)